Nanocarrier mediated Tumor specific Co-delivery of dual-action Cisplatin (IV) prodrug and venetoclax for improved Therapeutic outcomes in triple negative Breast Cancer treatment
Development of 3D tumor model for evaluation of anticancer drugs and formulations
